Request to Join
has invited you to join this group
To explore the potential of clinical trial data sharing, the New England Journal of Medicine (NEJM) is hosting a challenge: use the data underlying a recent NEJM article to identify a novel clinical finding that advances medical science.
To explore the potential of clinical trial data sharing, the New England Journal of Medicine (NEJM) is hosting a challenge: use the data underlying a recent NEJM article to identify a novel clinical finding that advances medical science.
Browse the session catalog at events.nejm.org to view the recorded sessions and feel free to share the link with any colleagues or peers who would find the discussion of relevance.
View the top three entries and read the novel findings that were identified using the SPRINT trial data. Read more »
Browse all the SPRINT Challenge submissions. Read more »
We also want to thank the SPRINT trial investigators who worked diligently to release the data underlying the NEJM article one-year in advance and the staff at NHLBI’s BioLINCC depository for all of their collaborative support.
Join us for the free web event Aligning Incentives for Sharing Clinical Trial Data on April 3–4, 2017. View the SPRINT Challenge winners’ presentations and hear what was learned from the SPRINT Challenge directly from the SPRINT PIs, data analysts, patient participants, and the NHLBI repository. Learn more »
Clinical trials drive medical advances and have a direct impact on health outcomes. Thoughtful, transparent systems for the responsible sharing of clinical trial data are important in maximizing the contribution of the patients who put themselves at risk by participating in clinical trials. The New England Journal of Medicine (NEJM) is committed to working with the global medical community to make the sharing of clinical trial data an effective, efficient and sustainable part of biomedical research.
To initiate an open conversation among researchers, data analysts, and patient participants, NEJM is hosting a web event, Aligning Incentives for Sharing Clinical Trial Data summit, on April 3–4, 2017. Leading up to the event, NEJM is sponsoring a SPRINT Data Analysis Challenge to demonstrate how clinical trial data can be used to identify additional advances in human health.
Are you up to the SPRINT Challenge to explore the potential from sharing clinical trial data? If so, NEJM challenges you to analyze the dataset underlying the SPRINT article — A Randomized Trial of Intensive versus Standard Blood-Pressure Control (N Engl J Med 373: 2103-2116) — and identify a novel scientific or clinical finding to advance medical science.
HOW TO ENTER
All are welcome to register to 'Follow' the SPRINT Challenge. Stay informed of news, updates and important deadlines. Comment on Challenge Round submissions and cast your crowdvote for the best entry.
Visit the How To Enter page for step-by-step instructions and tips for expediting the data request process, which requires an Institutional Review Board (IRB) approval or exemption certificate, and a data use agreement signed by you and your institution.
The SPRINT data underlying the NEJM article will be made available on November 1, 2016. In the Qualifying Round, reanalyze the SPRINT data to answer one question and progress to the Challenge Round.
In the Challenge Round, use the SPRINT data and any other publicly available dataset to identify and submit a novel clinical finding.
Take a shot at making a valuable contribution and you could win a prize and a chance to present at the Aligning Incentives for Sharing Clinical Trial Data summit.